TY - JOUR T1 - Quantifying superspreading for COVID-19 using Poisson mixture distributions JF - medRxiv DO - 10.1101/2020.11.27.20239657 SP - 2020.11.27.20239657 AU - Cécile Kremer AU - Andrea Torneri AU - Sien Boesmans AU - Hanne Meuwissen AU - Selina Verdonschot AU - Koen Vanden Driessche AU - Christian L. Althaus AU - Christel Faes AU - Niel Hens Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/30/2020.11.27.20239657.abstract N2 - The number of secondary cases is an important parameter for the control of infectious diseases. When individual variation in disease transmission is present, like for COVID-19, the number of secondary cases is often modelled using a negative binomial distribution. However, this may not be the best distribution to describe the underlying transmission process. We propose the use of three other offspring distributions to quantify heterogeneity in transmission, and we assess the possible bias in estimates of the offspring mean and its overdispersion when the data generating distribution is different from the one used for inference. We find that overdispersion estimates may be biased when there is a substantial amount of heterogeneity, and that the use of other distributions besides the negative binomial should be considered. We revisit three previously analysed COVID-19 datasets and quantify the proportion of cases responsible for 80% of transmission, p80%, while acknowledging the variation arising from the assumed offspring distribution. We find that the number of secondary cases for these datasets is better described by a Poisson-lognormal distribution.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has received funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (Grant agreement number 101003688). AT acknowledges support from the special research fund of the University of Antwerp. NH and AT acknowledge funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 682540 - TransMID).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data from Hong Kong and India used in this study are publicly available. The empirical offspring distribution from Rwanda and the code to generate data as used in the simulation study, as well as all R code used in the analyses, are available on GitHub (https://github.com/cecilekremer/PoiMixtSS). https://github.com/cecilekremer/PoiMixtSS ER -